![]()
Daily Range
Daily RangeToday's Low
₹ 1,794.10
Today's High
₹ 1,825.95
![]()
52 Weeks Range
52 Weeks Low
₹ 789.90
52 Weeks High
₹ 1,072.15
![]()
Momentum of the Stock
Momentum of the Stock ![]()
Bullish
Bullish![]()
Circuit Limit
Lower
₹ 1,641.00
Upper
₹ 2,005.60
![]()
Financials Strength Score
Financials Strength Score 7 Strong19
Piotroski Score
![]()
Company Profile
Sun Pharmaceutical Industries Limited, a generic pharmaceutical company, develops, manufactures, and markets branded and generic formulations and active pharmaceutical ingredients (APIs) in India and internationally. The company offers formulations in various therapeutic areas, including central nervous system, dermatology, cardiology, oncology and ophthalmic, neuro-psychiatry, gastroenterology, anti-infectives, diabetology, pain/analgesics, vitamins/minerals/nutrients, respiratory, gynaecology, urology, ophthalmology, orthopaedic, nephrology, dental, and other areas. It also provides APIs for anti-cancers, peptides, steroids, sex hormones, and controlled substances, as well as over-the-counter products. Sun Pharmaceutical Industries Limited was founded in 1983 and is based in Mumbai, India.
![]()
Companies under the same Group
Companies under the same Group
No Data Found
![]()
Key Metrics
Key MetricsStandalone
Consolidated
No of shares Outstanding
239.9 Cr.
EPS-TTM
₹46.07
Face Value
₹1.00
Book Value
₹288.06
Net Asset Value
₹233.38
ROE
16.46%
ROA
11.85%
ROCE
17.24%
Dividend Yield
0.75%
Total Debt
₹ 0.0 Cr.
Sales Growth
13.53%
PAT Growth
151.36%
Financials
| Particulars | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 | FY 2014 | FY 2013 | FY 2012 | FY 2011 | FY 2010 | FY 2009 | FY 2008 | FY 2007 | FY 2006 | FY 2005 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Current Assets | 39,861.9 | 34,864.6 | 30,442.1 | 31,654.2 | 31,069.2 | 31,635.9 | 32,947.1 | 29,934.1 | 28,915.8 | 18,686.5 | 11,503.0 | 10,293.4 | 7,593.1 | 5,294.2 | 5,068.5 | 4,033.7 | 3,007.8 | 2,662.2 | 2,352.7 |
| Total Non-Current Assets | 37,696.0 | 32,093.6 | 33,668.2 | 33,423.0 | 31,069.8 | 30,473.1 | 25,963.8 | 22,440.0 | 18,055.8 | 9,497.6 | 8,161.9 | 5,497.0 | 4,279.8 | 3,568.0 | 3,004.3 | 1,936.4 | 1,318.2 | 1,292.5 | 965.4 |
| Total Assets | 77,579.4 | 66,958.2 | 64,110.3 | 65,077.2 | 62,138.9 | 62,109.0 | 58,917.4 | 52,381.3 | 46,971.6 | 28,184.1 | 19,665.1 | 15,790.5 | 11,873.1 | 8,862.1 | 8,072.8 | 5,970.1 | 4,326.0 | 3,954.7 | 3,318.1 |
| Total Current Liabilities | 19,906.4 | 17,208.5 | 16,145.6 | 15,706.4 | 17,339.6 | 19,864.3 | 17,887.0 | 13,144.0 | 16,146.8 | 5,989.6 | 2,841.3 | 2,618.5 | 1,730.9 | 757.9 | 719.8 | 637.3 | 305.5 | 351.5 | 258.7 |
| Total Non-Current Liabilities | -1,643.1 | -1,316.4 | -1,515.2 | 246.1 | 76.7 | 46.4 | 599.9 | 2,169.6 | 2,335.5 | 1,748.4 | 199.0 | -225.2 | -188.3 | 82.1 | 111.0 | 152.8 | 1,203.9 | 1,980.0 | 1,912.6 |
| Shareholder's Funds | 55,995.4 | 48,011.2 | 46,462.8 | 45,264.5 | 41,409.1 | 38,314.1 | 36,639.7 | 32,982.5 | 25,638.1 | 18,525.0 | 14,989.7 | 12,235.8 | 9,483.3 | 7,828.9 | 7,044.9 | 4,991.5 | 2,772.8 | 1,590.2 | 1,130.7 |
| Total Liabilities | 77,579.4 | 66,958.2 | 64,110.3 | 65,077.2 | 62,138.9 | 62,109.0 | 58,917.4 | 52,381.3 | 46,971.6 | 28,184.1 | 19,665.1 | 15,790.5 | 11,873.1 | 8,862.1 | 8,072.8 | 5,970.1 | 4,326.0 | 3,954.7 | 3,318.1 |
![]()
Financial Statement Analysis
Debt to Equity Ratio
The Industry Debt to Equity Ratio stands at 0.23, vs the Debt to Equity Ratio of 0.18, which results in a Positive aspect.
Current Ratio
The Industry Current Ratio stands at 2.30, vs the Current Ratio of 2.02, which results in a Negative aspect.
Price to BV
The Industry Price to BV stands at 7.44, vs the Price to BV of 6.72, which results in a Negative aspect.
Quick Ratio
The Industry Quick Ratio stands at 1.60, vs the Quick Ratio of 1.51, which results in a Negative aspect.
| Particulars | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 | FY 2014 | FY 2013 | FY 2012 | FY 2011 | FY 2010 | FY 2009 | FY 2008 | FY 2007 | FY 2006 | FY 2005 | FY 2004 | FY 2003 | FY 2002 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Income | 43,885.7 | 38,654.5 | 33,498.1 | 32,837.5 | 29,065.9 | 26,415.5 | 31,308.1 | 28,108.6 | 27,392.0 | 16,080.4 | 11,299.9 | 8,019.5 | 5,727.9 | 4,007.5 | 4,272.3 | 3,356.5 | 2,135.9 | 1,636.8 | 1,185.3 | 990.5 | 832.3 | 697.4 |
| Total Expenditure | 32,424.2 | 28,772.7 | 25,030.4 | 25,863.4 | 22,792.3 | 20,880.7 | 21,625.9 | 19,950.3 | 19,543.2 | 9,080.7 | 6,403.8 | 4,820.6 | 3,766.2 | 2,644.6 | 2,412.1 | 1,805.4 | 1,463.9 | 1,147.3 | 768.6 | 588.2 | 554.0 | 494.3 |
| Operating Profit(Excl OI) | 12,281.3 | 11,319.2 | 9,326.9 | 7,625.7 | 7,333.1 | 6,446.9 | 10,712.4 | 8,816.6 | 8,414.4 | 7,552.0 | 5,284.3 | 3,675.8 | 2,317.9 | 1,574.3 | 2,078.3 | 1,705.0 | 927.5 | 673.5 | 474.4 | 417.1 | 289.9 | 207.8 |
| Add: Other Income | 819.9 | 1,437.4 | 859.2 | 651.6 | 1,059.4 | 912.1 | 1,030.2 | 658.3 | 565.6 | 552.4 | 388.2 | 476.9 | 356.2 | 211.5 | 218.1 | 153.9 | 255.5 | 184.0 | 57.7 | 14.9 | 11.6 | 4.7 |
| Operating Profit | 12,281.3 | 11,319.2 | 9,326.9 | 7,625.7 | 7,333.1 | 6,446.9 | 10,712.4 | 8,816.6 | 8,414.4 | 7,552.0 | 5,284.3 | 3,675.8 | 2,317.9 | 1,574.3 | 2,078.3 | 1,705.0 | 927.5 | 673.5 | 474.4 | 417.1 | 289.9 | 207.8 |
| Less: Interest | 172.0 | 127.4 | 141.4 | 302.7 | 555.3 | 517.6 | 399.8 | 523.2 | 579.0 | 44.2 | 43.2 | 28.2 | 73.9 | 6.2 | 5.9 | 8.8 | 12.7 | 15.6 | 12.9 | 7.3 | 2.9 | 3.6 |
| PBDT | 12,109.3 | 11,191.9 | 9,185.5 | 7,323.0 | 6,777.8 | 5,929.3 | 10,312.6 | 8,293.3 | 7,835.4 | 7,507.8 | 5,241.2 | 3,647.6 | 2,244.0 | 1,568.2 | 2,072.5 | 1,696.3 | 914.8 | 657.9 | 461.5 | 409.8 | 287.0 | 204.2 |
| Less: Depreciation Amortization | 2,529.4 | 2,143.7 | 2,080.0 | 2,052.8 | 1,753.3 | 1,499.8 | 1,264.8 | 1,037.5 | 1,194.7 | 409.2 | 336.2 | 291.2 | 204.9 | 153.3 | 123.3 | 96.9 | 81.3 | 61.0 | 40.6 | 28.6 | 21.2 | 17.4 |
| PBT & Exceptional Items | 9,579.9 | 9,048.1 | 7,105.5 | 5,270.2 | 5,024.6 | 4,429.5 | 9,047.9 | 7,255.8 | 6,640.7 | 7,098.6 | 4,905.0 | 3,356.5 | 2,039.2 | 1,414.8 | 1,949.2 | 1,599.4 | 833.5 | 596.9 | 420.9 | 381.2 | 265.8 | 186.8 |
| Less: Exceptional Income Expenses | -171.5 | -4,566.8 | -4,306.1 | -260.6 | -1,214.4 | -950.5 | 0.0 | -685.2 | -237.8 | -2,517.4 | -583.6 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 5.0 | 0.0 | -2.6 |
| Profit Before Tax | 9,408.4 | 4,481.3 | 2,799.4 | 5,009.6 | 3,810.2 | 3,479.0 | 9,047.9 | 6,570.6 | 6,402.9 | 4,581.2 | 4,321.4 | 3,356.5 | 2,039.2 | 1,414.8 | 1,949.2 | 1,599.4 | 833.5 | 596.9 | 420.9 | 386.2 | 265.8 | 184.1 |
| Less: Taxation | 847.6 | 1,075.5 | 514.7 | 822.8 | 600.9 | 911.0 | 1,211.6 | 913.8 | 914.7 | 702.2 | 845.6 | 313.2 | 128.6 | 67.9 | 71.2 | 48.5 | -6.7 | 23.9 | 20.5 | 55.4 | 21.5 | 16.0 |
| Profit After Tax | 8,560.8 | 3,405.8 | 2,284.7 | 4,186.8 | 3,209.3 | 2,567.9 | 7,836.3 | 5,656.9 | 5,488.2 | 3,879.0 | 3,475.9 | 3,043.3 | 1,910.6 | 1,347.0 | 1,878.0 | 1,550.9 | 840.2 | 573.0 | 400.4 | 330.8 | 244.4 | 168.1 |
| Earnings Per Share | 3.5 | 1.4 | 1.2 | 1.6 | 1.1 | 0.9 | 2.9 | 1.9 | 2.2 | 1.5 | 1.4 | 1.3 | 0.9 | 0.7 | 0.9 | 0.7 | 0.4 | 0.3 | 0.2 | 0.2 | 0.1 | 0.1 |
![]()
Financial Statement Analysis
PAT Margin
The Industry PAT Margin stands at 9.78, vs the PAT Margin of 7.05, which results in a Negative aspect.
Dividend Yield
The Industry Dividend Yield stands at 0.54, vs the Dividend Yield of 0.72, which results in a Positive aspect.
PAT Growth
The Industry PAT Growth stands at 30.72, vs the PAT Growth of 30.46, which results in a Negative aspect.
PE Ratio
The Industry PE Ratio stands at 48.79, vs the PE Ratio of 43.01, which results in a Negative aspect.
| Particulars | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 | FY 2014 | FY 2013 | FY 2012 | FY 2011 | FY 2010 | FY 2009 | FY 2008 | FY 2007 | FY 2006 | FY 2005 | FY 2004 | FY 2003 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Profit Before Tax | 9,408.4 | 4,481.3 | 2,799.4 | 5,009.6 | 3,810.2 | 3,479.0 | 9,047.9 | 6,570.6 | 6,402.9 | 4,581.2 | 4,314.9 | 3,355.4 | 2,036.0 | 1,414.8 | 1,949.2 | 1,599.4 | 833.5 | 596.9 | 420.9 | 381.2 | 266.1 |
| Tax Paid | -1,509.8 | 969.2 | -1,002.9 | -1,345.9 | -886.4 | -741.7 | -2,057.1 | -1,988.5 | -1,740.4 | -788.9 | -1,073.5 | -226.8 | -69.3 | -174.5 | -169.0 | -182.2 | -44.4 | -16.5 | -10.7 | -14.4 | -16.8 |
| Adjustment | 2,722.6 | 1,975.0 | 1,809.9 | 1,992.5 | 1,968.7 | 1,382.2 | 500.7 | 1,856.9 | 773.6 | -40.2 | 160.0 | 111.1 | -171.2 | -23.6 | 381.8 | 21.5 | -134.3 | -75.5 | 31.0 | 40.1 | 20.5 |
| Changes In Working Capital | 9,408.4 | 4,481.3 | 2,799.4 | 5,009.6 | 3,810.2 | 3,479.0 | 9,047.9 | 6,570.6 | 6,402.9 | 4,581.2 | 4,314.9 | 3,355.4 | 2,036.0 | 1,414.8 | 1,949.2 | 1,599.4 | 833.5 | 596.9 | 420.9 | 381.2 | 266.1 |
| Cash Flow after changes in Working Capital | 6,469.2 | 8,015.3 | 7,173.3 | 7,900.7 | 3,082.9 | 4,648.9 | 9,139.3 | 8,674.3 | 7,356.1 | 4,748.1 | 4,430.1 | 2,461.2 | 2,352.4 | 955.6 | 2,333.9 | 687.1 | 283.8 | 203.7 | 386.1 | 302.2 | 168.0 |
| Cash Flow from Operating Activities | 4,959.3 | 8,984.5 | 6,170.4 | 6,554.8 | 2,196.5 | 3,907.2 | 7,082.2 | 6,685.9 | 5,615.7 | 3,959.2 | 3,356.6 | 2,234.5 | 2,283.1 | 781.1 | 2,164.9 | 505.0 | 239.5 | 187.2 | 375.4 | 287.8 | 151.3 |
| Cash Flow from Investing Activities | -7,943.7 | -5,724.7 | 536.2 | -2,588.8 | -681.3 | -3,370.8 | -4,221.6 | -4,371.6 | -2,865.7 | -2,366.8 | -2,635.1 | -862.7 | -1,847.7 | -213.7 | -1,773.0 | -606.0 | 63.9 | 75.8 | -635.2 | -432.1 | -77.2 |
| Cash Flow from Financing Activities | 2,376.1 | -5,193.5 | -5,980.5 | -5,715.1 | -2,730.5 | -1,539.3 | -2,285.4 | -1,888.5 | -1,186.5 | 506.6 | -665.0 | -544.4 | -804.2 | -346.4 | -266.6 | 66.1 | -449.8 | -14.6 | 1,364.0 | 177.3 | 72.8 |
| Net Cash Inflow / Outflow | -608.3 | -1,933.7 | 726.1 | -1,749.2 | -1,215.3 | -1,002.9 | 575.2 | 425.7 | 1,563.5 | 2,099.0 | 56.5 | 827.4 | -368.8 | 221.0 | 125.3 | -35.0 | -146.4 | 248.5 | 1,104.3 | 33.0 | 146.9 |
| Opening Cash & Cash Equivalents | 4,508.3 | 6,273.0 | 5,676.6 | 7,062.3 | 7,906.5 | 8,642.4 | 8,031.7 | 7,183.5 | 4,358.7 | 2,069.1 | 1,752.7 | 810.5 | 633.9 | 451.2 | 326.0 | 1,278.3 | 1,532.4 | 1,180.9 | 94.6 | 81.6 | 25.5 |
| Closing Cash & Cash Equivalent | 4,623.7 | 4,508.3 | 6,273.0 | 5,676.6 | 7,062.3 | 7,906.5 | 8,642.4 | 8,031.7 | 7,285.6 | 4,358.7 | 2,069.1 | 1,752.7 | 810.5 | 672.2 | 451.2 | 1,243.3 | 1,386.0 | 1,532.4 | 1,180.9 | 94.6 | 81.6 |
![]()
Financial Statement Analysis
PFCF Ratio
The Industry PFCF Ratio stands at 27.34, vs the PFCF Ratio of 15.10, which results in a Negative aspect.
PCF RATIO
The Industry PCF RATIO stands at 24.37, vs the PCF RATIO of 12.89, which results in a Negative aspect.
| Particulars | Sep 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | Dec 2021 | Sep 2021 | Jun 2021 | Mar 2021 | Dec 2020 | Sep 2020 | Jun 2020 | Mar 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Sales | 132,913.9 | 119,829.0 | 123,807.0 | 121,924.1 | 119,408.4 | 109,306.7 | 112,410.0 | 109,523.0 | 107,618.0 | 94,467.6 | 98,630.6 | 96,259.3 | 97,187.4 | 85,229.8 | 88,367.8 | 85,531.3 | 75,852.5 | 81,849.4 |
| Total Income | 137,734.8 | 125,888.4 | 127,554.6 | 124,860.2 | 121,473.2 | 113,039.5 | 114,149.0 | 110,375.0 | 109,096.0 | 97,213.7 | 102,956.0 | 98,488.2 | 99,511.4 | 86,339.8 | 92,233.6 | 88,089.1 | 78,182.0 | 82,871.7 |
| Total Expenditure | 94,805.2 | 89,477.5 | 90,284.3 | 90,130.3 | 86,111.1 | 81,285.4 | 82,372.5 | 79,957.3 | 80,230.4 | 72,674.1 | 72,567.3 | 69,959.9 | 69,775.4 | 64,745.4 | 65,022.7 | 63,598.5 | 58,209.0 | 68,219.3 |
| PBIDT (Excl OI) | 38,108.7 | 30,351.5 | 33,522.7 | 31,793.8 | 33,297.3 | 28,021.3 | 30,037.5 | 29,565.7 | 27,387.6 | 21,793.5 | 26,063.3 | 26,299.4 | 27,412.0 | 20,484.4 | 23,345.1 | 21,932.8 | 17,643.5 | 13,630.1 |
| Other Income | 4,820.9 | 6,059.4 | 3,747.6 | 2,936.1 | 2,064.8 | 3,732.8 | 1,738.8 | 852.2 | 1,478.1 | 2,746.1 | 4,325.1 | 2,228.9 | 2,324.0 | 1,110.0 | 3,865.8 | 2,557.8 | 2,329.5 | 1,022.3 |
| Operating Profit | 42,929.6 | 36,410.9 | 37,270.3 | 34,729.9 | 35,362.1 | 31,754.1 | 31,776.0 | 30,417.7 | 28,865.3 | 24,539.6 | 30,388.4 | 28,528.3 | 29,736.0 | 21,594.4 | 27,210.9 | 24,490.6 | 19,973.0 | 14,652.4 |
| Interest | 691.7 | 735.7 | 347.3 | 492.9 | 808.8 | 927.4 | 461.8 | 193.9 | 136.9 | 373.4 | 189.7 | 359.5 | 350.9 | 301.0 | 261.0 | 332.8 | 519.5 | 517.8 |
| Exceptional Items | 0.0 | -1,016.4 | -698.1 | 0.0 | -3,228.7 | -1,714.5 | 0.0 | 0.0 | 0.0 | -39,357.5 | 0.0 | 0.0 | -6,310.7 | -6,728.1 | 0.0 | 0.0 | -36,333.3 | -2,606.4 |
| PBDT | 42,237.9 | 34,658.8 | 36,224.9 | 34,237.0 | 31,324.6 | 29,112.2 | 31,314.2 | 30,223.8 | 28,728.4 | -15,191.3 | 30,198.7 | 28,168.8 | 23,074.4 | 14,565.3 | 26,949.9 | 24,157.8 | -16,879.8 | 11,528.2 |
| Depreciation | 6,259.1 | 6,503.6 | 6,221.4 | 6,328.2 | 6,513.2 | 6,715.3 | 6,599.5 | 6,099.5 | 5,880.0 | 5,564.7 | 5,536.8 | 5,303.7 | 5,032.2 | 5,534.9 | 5,319.4 | 4,986.0 | 4,959.2 | 5,753.8 |
| Profit Before Tax | 35,978.8 | 28,155.2 | 30,003.5 | 27,908.8 | 24,811.4 | 22,396.9 | 24,714.7 | 24,124.3 | 22,848.4 | -20,756.0 | 24,661.9 | 22,865.1 | 18,042.2 | 9,030.4 | 21,630.5 | 19,171.8 | -21,839.0 | 5,774.4 |
| Tax | 5,672.1 | 1,489.3 | 4,323.2 | 3,901.0 | 4,681.0 | 2,229.1 | 2,834.3 | 1,522.6 | 1,889.9 | 1,467.6 | 3,353.9 | 1,977.8 | 3,955.7 | 550.4 | 2,449.4 | -312.0 | 2,459.1 | 830.9 |
| Provisions and contingencies | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Profit After Tax | 30,306.7 | 26,665.9 | 25,680.3 | 24,007.8 | 20,130.4 | 20,167.8 | 21,880.4 | 22,601.7 | 20,958.5 | -22,223.6 | 21,308.0 | 20,887.3 | 14,086.5 | 8,480.0 | 19,181.1 | 19,483.8 | -24,298.1 | 4,943.5 |
| Net Profit | 30,306.7 | 26,665.9 | 25,680.3 | 24,007.8 | 20,130.4 | 20,167.8 | 21,880.4 | 22,601.7 | 20,958.5 | -22,223.6 | 21,308.0 | 20,887.3 | 14,086.5 | 8,480.0 | 19,181.1 | 19,483.8 | -24,298.1 | 4,943.5 |
| ADDITIONAL INFOS: | ||||||||||||||||||
| Equity Capital | 2,399.3 | 2,399.3 | 2,399.3 | 2,399.3 | 2,399.3 | 2,399.3 | 2,399.3 | 2,399.3 | 2,399.3 | 2,399.3 | 2,399.3 | 2,399.3 | 2,399.3 | 2,399.3 | 2,399.3 | 2,399.3 | 2,399.3 | 2,399.3 |
| Reserves | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| EPS | 12.7 | 11.1 | 10.5 | 9.9 | 8.4 | 8.3 | 9.0 | 9.4 | 8.6 | -9.5 | 8.6 | 8.5 | 6.0 | 3.7 | 7.7 | 7.6 | -6.9 | 1.7 |
| Operating Profit Margin | 32.3 | 30.4 | 30.1 | 28.5 | 29.6 | 29.1 | 28.3 | 27.8 | 26.8 | 26.0 | 30.8 | 29.6 | 30.6 | 25.3 | 30.8 | 28.6 | 26.3 | 17.9 |
| Net Profit Margin | 22.8 | 22.3 | 20.7 | 19.7 | 16.9 | 18.5 | 19.5 | 20.6 | 19.5 | -23.5 | 21.6 | 21.7 | 14.5 | 9.9 | 21.7 | 22.8 | -32.0 | 6.0 |
![]()
Financial Statement Analysis
Mcap Growth
The Industry Mcap Growth stands at 19.96, vs the Mcap Growth of -26.51, which results in a Negative aspect.
Net Sales Growth
The Industry Net Sales Growth stands at 11.06, vs the Net Sales Growth of 12.98, which results in a Positive aspect.
Technicals
![]()
Pivot Levels
Pivot Levels Check Advanced Levels ![]()
| Type | Classic | Woodie | Camarilla |
|---|---|---|---|
| R4 | 1,872.55 | 1,904.99 | 1,826.37 |
| R3 | 1,857.02 | 1,856.63 | 1,817.61 |
| R2 | 1,841.48 | 1,841.29 | 1,814.69 |
| R1 | 1,825.17 | 1,824.78 | 1,811.77 |
| Pivot | 1,809.63 | 1,809.44 | 1,809.63 |
| S1 | 1,793.32 | 1,792.93 | 1,805.93 |
| S2 | 1,777.78 | 1,777.59 | 1,803.01 |
| S3 | 1,761.47 | 1,761.08 | 1,800.09 |
| S4 | 1,745.15 | 1,713.89 | 1,791.33 |
(All Values are in INR)
The Pivot level gives the user an indication about key support & resistance levels for a selected stock.
EMA & SMA Levels 
![]()
Beta
Beta 1 Day
0.46
1 Week
0.46
1 Month
0.45
![]()
Indicators
Stoch RSI
100.00
Bearish
RSI
79.39
Bearish
ROC
-0.25
Bearish
UltimateOscillator
54.21
Neutral
Williams Indicator
-37.13
Neutral
CCI Indicator
52.89
Neutral
MACD
-1,754.79
Bearish
Stochastic Indicator
69.30
Neutral
ATR
55.98
High Volatility
Corporate Actions
![]()
Corporate Actions - Board Meet
Corporate Actions - Board Meet | Ex-Date | Ratio | Record Date |
|---|
| Ex-Date | Ratio | Record Date |
|---|---|---|
| Announcement Date | Dividend Amount | Dividend Percentage of FV | Dividend Type |
|---|---|---|---|
| 09-02-2024 | 8.50 | 850 | Interim |
| 28-07-2023 | 4.00 | 400 | Final |
| 08-02-2023 | 7.50 | 750 | Interim |
| 19-08-2022 | 3.00 | 300 | Final |
| 09-02-2022 | 7.00 | 700 | Interim |
| 23-08-2021 | 2.00 | 200 | Final |
| Date Of Conduct | Board Meeting Details |
|---|---|
| 28-10-2024 | Quarterly Results |
| 31-01-2024 | Interim Dividend & Quarterly Results |
| 01-11-2023 | Quarterly Results |
| 03-08-2023 | Quarterly Results |
| 26-05-2023 | Final Dividend & Audited Results |
| 31-01-2023 | Quarterly Results & Interim Dividend |
| 01-11-2022 | Quarterly Results |
| 29-07-2022 | Quarterly Results |
| 30-05-2022 | Final Dividend & Audited Results |
| 31-01-2022 | Interim Dividend |
| 02-11-2021 | Quarterly Results |
| 30-07-2021 | Quarterly Results |
| 27-05-2021 | Final Dividend & Audited Results |
Frequently Asked Questions
The share price of SUNPHARMA is 1808.85.
You can easily buy SUNPHARMA shares by opening a Demat and trading Account from Enrich money free of cost. You can trade using their Web Trading Platform or Mobile App.
The Market Capitalization of Sun Pharma Inds.share as on today is433,919.73Cr.
The Trailing Twelve Months (TTM) PE Ratio of Sun Pharma Inds.is39.25
The Earnings per Share (EPS) of Sun Pharma Inds.is46.07
The 52 Week Low of 1,208.55, and 52 Week High is 1,960.35
The share price changes based on the Share Market's Demand & Supply. Usually, the Beta of the Stock (Positive or Negative) measures the volatility of the stock. Based on this, the Sun Pharma Inds. share is 0.46 times volatile to the Index trend.